Back to search results

kTMP for Arm Weakness After Stroke

This study is testing a treatment called kTMP (kilohertz transcutaneous magnetic perturbations) for people who have arm weakness due to a stroke. kTMP is a low-intensity brain stimulation technique that aims to help with arm and hand recovery. Participants will either receive kTMP sham stimulation (inactive) followed by active kTMP stimulation, or active kTMP stimulation for 18 weeks. The study will measure how well your arm moves using a test called the Fugl Meyer Assessment. You may be able to join if you are an adult between 18 and 80 years old, have had a stroke causing weakness on one side of your body, and can communicate and understand the study. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 100 participants. It compares two groups: one receiving sham kTMP followed by active kTMP, and another receiving active kTMP for 18 weeks.
What's involved
Participants will have their arm movement assessed at enrollment, then at weeks 3, 6, 9, 12, 15, 18, and 34.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 34 weeks after enrollment, with assessments continuing after the treatment period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07277595

kTMP in Chronic Stroke

Not Yet Recruiting
NAAges 18–80InterventionalTreatment
University of California, San Francisco
~100 participants
Updated 2026-05-06 on ClinicalTrials.gov
What's tested:kTMP sham stimulation 9 weeks + active stimulation 9 weekskTMP 18 weeks

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Fugl Meyer Assessment
Measured over Enrollment, then weeks 3, 6, 9, 12, 15, 18, and 34.

Conditions

Stroke
Chronic Stroke Patients
Arm Weakness as a Consequence of Stroke

Explore related trials

Stroke

NCT07277595

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of California, San Francisco

    San Francisco, Californiano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Karunesh Ganguly, MD, PhD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

Karunesh Ganguly, MD, PhD
[email protected]
415-514-1252
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults age 18-80 years old who have had a stroke resulting in hemiplegia
Ability to communicate, understand, and give appropriate consent
Other criteria may apply

Exclusion

Significant cognitive impairment
inability to adhere to the study protocol or provide informed consent
pregnancy
additional criteria may apply

What this trial measures

  • Fugl Meyer AssessmentEnrollment, then weeks 3, 6, 9, 12, 15, 18, and 34.

    The Fugl-Meyer Assessment (FMA) is a structured evaluation used to measure motor recovery after a stroke, with a total score range of 0-226. Higher scores indicate better motor function, while lower scores reflect greater impairment.